InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-24.1%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Murphy Polly A., Director. Director active across 2 companies, notably Atea Pharmaceuticals, Inc.. In total, 7 filings have been published. Split: 3 buys · 0 sell. Total volume traded: €230k. History available since 20 December 2021. The latest transaction was filed on 5 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
29,600 sharesCommon StockSEC:0001193125-26-279718:0
1,530 shares0Common StockSEC:0001829248-26-000002:0
29,600 shares0Common StockSEC:0000950170-25-089607:0
33,150 shares0Common StockSEC:0000950170-24-074989:0
5,000 shares@ US$9.6766100.0% of flowCommon StockSEC:0001062993-22-022722:0
Ideal exit: 19 Aug 2023 (T+270)
12,000 shares@ US$8.566350.0% of flowCommon StockSEC:0000899243-21-049313
Ideal exit: 16 Sept 2022 (T+270)
12,000 shares@ US$8.56630.028% mcap50.0% of flowCommon StockSEC:0000899243-21-049313:0
Ideal exit: 16 Sept 2022 (T+270)
7 of 7 declarations
About Murphy Polly A.
Polly A. Murphy is a Director at Atea Pharmaceuticals, Inc. She contributes to the governance of the company, bringing her expertise in the pharmaceutical field. Her experience allows her to actively participate in strategic discussions within the board.
